Immunological aspects of ozone in rheumatoid arthritis and its role in patients with chronic pain syndrome, fibromyalgia, positive tested for antinuclear antibody (ANA).
DOI:
https://doi.org/10.7203/jo3t.6.7.2022.25973Palavras-chave:
fibromyalgia, medical ozoneResumo
Fibromyalgia is a long-term or chronic disorder. It is associated with widespread pain in the muscles and bones, areas of tenderness, and general fatigue. Symptoms like these are considered subjective, meaning they cannot be determined or measured by tests. Because its symptoms are subjective and there is no clear known cause, fibromyalgia is often misdiagnosed. Antinuclear Antibodies (ANA’s) directed against a variety of nuclear antigens have been detected in the serum of patients with many rheumatic and non rheumatic diseases. The lack of reproducible, objective tests for this disorder plays a role in some doctors questioning the disorder all together. Although it is more widely accepted in medical circles now than previously, some doctors and researchers do not consider fibromyalgia a real condition. According to our clinical studies, this can increase your risk of depression, with stems from a struggle in gaining acceptance for painful symptoms.Downloads
Downloads
Publicado
Como Citar
-
Resumo413
-
PDF 227
Edição
Secção
Licença
Journal of Ozone Therapy applies the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY NC 4.0) license to works we publish.
Under this license, authors retain ownership of the copyright for their content, but allow anyone to download, reuse, reprint, modify, distribute and/or copy the content as long as the original authors and source are cited. No permission is required from the authors or the publishers.
You may not use the material for commercial purposes.
Appropriate attribution can be provided by simply citing the original article, provide a link to the license, and indicate if changes were made.
You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.